Instrument validation study demonstrates structured assessment of disease burden in canine allergic dermatitis, suggesting improved tracking of treatment satisfaction.
Animal and owner quality-of-life (QoL) is pivotal in treatment decisions. Accurate measurement of owner-reported QoL and treatment satisfaction (TS) supports disease burden and treatment benefit evaluation.
No takes yet. Share an insight, caveat, or question.
Wells et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: